Shinomiya M, Chu W, Carlson R G, Weaver R F, Takusagawa F
Departments of Chemistry and Biochemistry, University of Kansas, Lawrence 66045-0046, USA.
Biochemistry. 1995 Jul 4;34(26):8481-91.
The crystal structure of the self-complementary DNA octamer d(GAAGCTTC)2 complexed with N8-actinomycin D (N8AMD) has been determined at 3.0 A resolution (space group: P3(1)21; unit cell: a = 62.30, b = 62.30, c = 42.97 A; R = 0.173 for 1845 reflections). The DNA structure was severely distorted by the N8AMD bound intercalatively into the middle dinucleotide, 5'-GC-3'. The two cyclic depsipeptides, which differ from each other in overall conformation, lie in the minor groove. The complex is further stabilized by forming base--peptide and chromophore--backbone hydrogen bonds. The complexes are stacked together to form a pseudocontinuous helix running through the crystals. The structure of d(GAAGCTTC)2-actinomycin D (AMD) crystallized in the space group C2 [Kamitori S., & Takusagawa, F. (1992) J. Mol. Biol. 225, 445-456] was re-refined in order to compare it directly to the N8AMD complex structure. The asymmetrical binding mode of AMD has been confirmed on the basis of the two complex structures. The crystal structures of the N8AMD and AMD complexes bound to the same d(GAAGCTTC)2 differed by a root-mean-square deviation on all atom positions of 1.77 A, but most of the structural differences can be attributed to molecular packing in two different crystal forms, and not to structural differences induced by the interaction with the intercalating agents. However, the DNA binding and biological characteristics of N8AMD and AMD are quite different from each other. The DNA association constant of N8AMD is 33-fold less than that of AMD in an aqueous solution. N8AMD required a concentration > 10.0 microM to inhibit RNA synthesis activity in HeLa cells by 50%, whereas AMD reached to the same inhibitory level at only 35 nM. The structure of the DNA-N8AMD complex suggested that substitution of the N-methyl-L-valine residue in the cyclic depsipeptide with a N-methyl-D-valine residue might increase the hydrophobic interaction with the minor groove of the DNA. Thus the DNA association constant and RNA synthesis inhibitory activities of 5,5'-N-methyl-D-valine AMD (D-MeVal-AMD) have also been determined. The DNA association constant of D-MeVal-AMD is more than 2-fold greater than that of AMD, and the RNA synthesis inhibitory activity is about 20-fold greater.
已确定与 N8-放线菌素 D(N8AMD)复合的自互补 DNA 八聚体 d(GAAGCTTC)2 的晶体结构,分辨率为 3.0 Å(空间群:P3(1)21;晶胞参数:a = 62.30,b = 62.30,c = 42.97 Å;1845 个反射的 R = 0.173)。N8AMD 以插入方式结合到中间的二核苷酸 5'-GC-3'中,使 DNA 结构严重扭曲。两个环肽在整体构象上彼此不同,位于小沟中。通过形成碱基 - 肽和发色团 - 主链氢键,复合物进一步稳定。这些复合物堆叠在一起形成贯穿晶体的假连续螺旋。对在空间群 C2 中结晶的 d(GAAGCTTC)2-放线菌素 D(AMD)的结构进行了重新精修,以便直接与 N8AMD 复合物结构进行比较。基于这两种复合物结构,已证实了 AMD 的不对称结合模式。与相同的 d(GAAGCTTC)2 结合的 N8AMD 和 AMD 复合物的晶体结构在所有原子位置上的均方根偏差为 1.77 Å,但大多数结构差异可归因于两种不同晶体形式中的分子堆积,而不是由与插入剂相互作用引起的结构差异。然而,N8AMD 和 AMD 的 DNA 结合及生物学特性彼此有很大不同。在水溶液中,N8AMD 的 DNA 结合常数比 AMD 小 33 倍。N8AMD 需要浓度 > 10.0 μM 才能在 HeLa 细胞中抑制 RNA 合成活性 50%,而 AMD 仅在 35 nM 时就达到相同的抑制水平。DNA-N8AMD 复合物的结构表明,将环肽中的 N-甲基-L-缬氨酸残基替换为 N-甲基-D-缬氨酸残基可能会增加与 DNA 小沟的疏水相互作用。因此,还测定了 5,5'-N-甲基-D-缬氨酸 AMD(D-MeVal-AMD)的 DNA 结合常数和 RNA 合成抑制活性。D-MeVal-AMD 的 DNA 结合常数比 AMD 大 2 倍多,RNA 合成抑制活性约大 20 倍。